- Controversies in borderline ovarian tumors
-
Seong SJ, Kim DH, Kim MK, Song T
- KMID: 2345926
- J Gynecol Oncol.
- 2015 Oct;26(4):343-349.
- doi: 10.3802/jgo.2015.26.4.343
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer
-
Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich , Paley P
- KMID: 2413208
- J Gynecol Oncol.
- 2017 Nov;28(6):e82.
- doi: 10.3802/jgo.2017.28.e82
OBJECTIVE: The use of robotic radical hysterectomy has greatly increased in the treatment of early stage cervical cancer. We sought to compare surgical and oncologic outcomes of women undergoing robotic... -
- CITED
-
- Close
- SHARE
-
- Close
